Lupus & antiphospholipid syndrome

Serum lipidomic and metabolomic signatures link epicardial adipose tissue to cardiovascular diseases in SLE: a post-hoc analysis

Lupus Sci MedPublished Retrospective cohort study

Authors' conclusion

EAT volume is increased and associated with a distinct serum lipidomic and metabolomic signature in SLE.

Study context

Population
Patients with SLE followed at the French Referral Center (Pitié-Salpêtrière Hospital) who underwent a cardiac CT scan (mean age 43±14 years; 100% female)
Participants
179 patients
Outcome
Circulating metabolomic and lipidomic signatures associated with epicardial adipose tissue (EAT) in SLE
Methodological detailsmonocentric, post-hoc analysis
  • Monocentric
  • Post-hoc analysis

Main finding

As reported in the abstract

EATi volume
Mean EATi volume (mL/m²), ±SD
63±37
Increased EATi volume (>68 mL/m²), n (%)
61 (34.1%)
Increased EATi volume significantly associated with age, BMI, triglyceride levels, coronary artery calcium (CAC) score, prior atherosclerotic CVD and metabolites/lipid species (n)
47
Key metabolites and lipid species independently associated with EATi volume (stepwise linear regression)
5
AUC of lipidomic and metabolic signature for EATi volume status prediction
0.80 (95% CI 0.73 to 0.87)

Observational data: associations, not effects.

Original publication

Serum lipidomic and metabolomic signatures link epicardial adipose tissue to cardiovascular diseases in SLE: a post-hoc analysis. Lupus Sci Med. Published 21 April 2026. doi:10.1136/lupus-2026-001993

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.